Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jinming Yu
Observed names:
J. Yu,
Jin-ming Yu
Institutions:
Shandong Tumor Hospital,
Shandong First Medical University
Observed institutions:
Weifang Medical University,
Shandong University,
Sichuan University,
West China Hospital of Sichuan University,
Shandong Tumor Hospital,
Qilu Hospital of Shandong University,
Shandong First Medical University
show all 7
ORCID:
0000-0002-4618-2490
Observed ORCID:
0000-0002-4618-2490
OpenAlex ID:
A5100648215
Potential immune escape mechanisms underlying the distinct clinical outcome of immune checkpoint blockades in small cell lung cancer
2019
·
Yaru Tian
, Xiaoyang Zhai
, et al.
·
Journal of Hematology & Oncology
·
108
PDF
End-of-life chemotherapy is associated with poor survival and aggressive care in patients with small cell lung cancer
2018
·
Yingming Zhu
, Ke Tang
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
23
Incorporation of circulating tumor cells and whole-body metabolic tumor volume of 18F-FDG PET/CT improves prediction of outcome in IIIB stage small-cell lung cancer
2018
·
Lei Fu
, Ying Zhu
, et al.
·
Chinese Journal of Cancer Research
·
21
Rationale and Design of the Phase 3 KEYLYNK-013 Study of Pembrolizumab With Concurrent Chemoradiotherapy Followed by Pembrolizumab With or Without Olaparib for Limited-Stage Small-Cell Lung Cancer
2022
·
Andreas Rimner
, Wei-Chu Victoria Lai
, et al.
·
Clinical Lung Cancer
·
20
PDF
Early, non-invasive detection of radiation-induced lung injury using PET/CT by targeting CXCR4
2023
·
Jinli Pei
, Kai Cheng
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
18
PET imaging of CXCR4 expression using [ 18 F]AlF-NOTA-QHY-04 for hematologic malignancy and solid tumors
2024
·
Kai Cheng
, Shijie Wang
, et al.
·
Theranostics
·
17
PDF
Association of Twice-Daily Radiotherapy With Subsequent Brain Metastases in Adults With Small Cell Lung Cancer
2019
·
Haiyan Zeng
, Rui Li
, et al.
·
JAMA Network Open
·
14
PDF
Exploring the value of FAP-targeted PET/CT in differentiating breast cancer molecular subtypes: a preliminary study
2024
·
Tianxin Liu
, Shengnan Xu
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
13
Safety and efficacy of SHR-1316 combined with chemotherapy and sequential chest radiotherapy as first-line therapy for extensive-stage small cell lung cancer (ES-SCLC): The results from a phase II single-arm trial.
2022
·
Dawei Chen
, Bing Zou
, et al.
·
Journal of Clinical Oncology
·
4
Hazard Model for Brain Metastases After Prophylactic Cranial Irradiation in Local Disease Small Cell Lung Cancer
2017
·
H. Zeng
, R. Li
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
2
C-X-C-chemokine-receptor-type-4 as a potential target for diagnosis and treatment of acute radiation-induced esophagitis
2025
·
Jinli Pei
, Shijie Wang
, et al.
·
International Immunopharmacology
·
1
P1.06B.10 Post-hoc Biomarker Analysis of Adebrelimab Plus Chemotherapy and Sequential Radiotherapy as First-Line Therapy for ES-SCLC
2024
·
L. Wang
, B. Zou
, et al.
·
Journal of Thoracic Oncology
·
1
PDF
Outcomes of anti-PD-L1 blockades plus etoposide and platinum (EP) as first-line therapy for extensive-stage small-cell lung cancer (ES-SCLC) with brain metastasis (BM).
2022
·
Yaru Tian
, Ji Ma
, et al.
·
Journal of Clinical Oncology
·
1
Phase 3 Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib vs. Concurrent Chemoradiation Therapy in Patients With Newly Diagnosed Limited-Stage Small-Cell Lung Cancer: KEYLYNK-013
2021
·
A. Rimner
, V. Lai
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
1
Abstract 6477: Tumor microenvironmental alterations and novel biomarkers in metastatic ovarian cancer identified with spatial transcriptomics
2025
·
Serge Yannick Ouedraogo
, Jinming Yu
, et al.
·
Cancer Research
Corrigendum to “C-X-C-chemokine-receptor-type-4 as a potential target for diagnosis and treatment of acute radiation-induced esophagitis” [International Immunopharmacology 150 (2025) 114289]
2025
·
Jinli Pei
, Shijie Wang
, et al.
·
International Immunopharmacology
106P Real-world outcomes in extensive-stage small cell lung cancer with PD-L1 inhibitors in China
2021
·
X. Meng
, J. Peng
, et al.
·
Annals of Oncology
Is CT-based selective nodal irradiation safe for clinical stage N0-1 LD-SCLC patients?
2013
·
Man Hu
, Bingjie Fan
, et al.
·
Journal of Clinical Oncology
Analysis of clinico-pathological factors which influence the expression of estrogen receptor in breast carcinoma
2006
·
Jinming Yu
·
Chinese Journal of Current Advances in General Surgery
[Current status of 18F-FDG PET in predicting outcome of cancer therapy].
2004
·
He-yi Gong
, Jin-ming Yu
·
PubMed
Show more works
View as search
Works count:
20
Citation count:
244
H-index:
8
I10-index:
8
Year
Topic
Type